Bendamustine side effects
Percentages show how often each reaction appears relative to total reports for bendamustine.
2 Disease Progression 9.9% 2,695
5 Drug Ineffective 4.9% 1,337
7 Febrile Neutropenia 4.3% 1,175
8 Thrombocytopenia 4.3% 1,163
13 Product Use In Unapproved Indication 2.8% 746
15 Malignant Neoplasm Progression 2.7% 723
These are voluntary reports and do not establish that bendamustine caused these reactions.
Report severity
90.7% Serious 24,596 reports
38.3% Hospitalizations 10,377 reports
19.6% Fatal 5,300 reports
Seriousness is determined by the reporter, not by OpenClaim.
Bendamustine drug interactions
Other drugs that appear in adverse event reports alongside bendamustine. Drugs flagged as a suspected cause appear in the first column. Drugs taken at the same time but not suspected appear in the second.
Also suspected
2 Cyclophosphamide 20.3% 5,502
3 Vincristine-sulfate 18.1% 4,910
4 Doxorubicin-hydrochloride 17.5% 4,753
5 Polatuzumab-vedotin-piiq 15.4% 4,173
Taken alongside
6 Sulfamethoxazole 4.7% 1,264
13 Vincristine-sulfate 2.6% 709
14 Doxorubicin-hydrochloride 2.5% 683
Co-occurrence in adverse event reports does not establish a drug interaction. Patients often take multiple medications, and these lists reflect prescribing patterns rather than causal relationships. Consult a healthcare provider about potential drug interactions.
Who reports bendamustine side effects
33.0% of bendamustine adverse event reports involve female patients and 48.9% involve male patients. The largest age group is elderly at 59%. These figures reflect who reports side effects, not underlying risk.
Sex
Female 33.0%
Male 48.9%
Unknown 18.1%
Age group
< 2 <0.1%
2–11 0.2%
12–17 0.6%
18–64 40.6%
65+ 58.5%
What is bendamustine used for
Conditions and purposes for which patients were taking bendamustine when the adverse event was reported.
Abdominal Mass Abdominal Neoplasm Acquired Haemophilia Acquired Immunodeficiency Syndrome Acute Leukaemia Acute Lymphocytic Leukaemia Acute Lymphocytic Leukaemia Recurrent Acute Myeloid Leukaemia Acute Promyelocytic Leukaemia Adult T-cell Lymphoma/leukaemia Agranulocytosis Allogenic Stem Cell Transplantation Amyloidosis Anaplastic Astrocytoma Anaplastic Large Cell Lymphoma T- And Null-cell Types
Showing 15 of 564 indications
ABDOMINAL MASS ABDOMINAL NEOPLASM ACQUIRED HAEMOPHILIA ACQUIRED IMMUNODEFICIENCY SYNDROME ACUTE LEUKAEMIA ACUTE LYMPHOCYTIC LEUKAEMIA ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT ACUTE MYELOID LEUKAEMIA ACUTE PROMYELOCYTIC LEUKAEMIA ADULT T-CELL LYMPHOMA/LEUKAEMIA AGRANULOCYTOSIS ALLOGENIC STEM CELL TRANSPLANTATION AMYLOIDOSIS ANAPLASTIC ASTROCYTOMA ANAPLASTIC LARGE CELL LYMPHOMA T- AND NULL-CELL TYPES ANAPLASTIC LARGE-CELL LYMPHOMA ANAPLASTIC LYMPHOMA KINASE GENE MUTATION ANGIOCENTRIC LYMPHOMA ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA REFRACTORY ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA STAGE III ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA STAGE IV ANTI-MYELIN-ASSOCIATED GLYCOPROTEIN ASSOCIATED POLYNEUROPATHY AUTOIMMUNE ANAEMIA AUTOIMMUNE HAEMOLYTIC ANAEMIA AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT Abdominal neoplasm Acquired Von Willebrand^s disease Acquired haemophilia Acute leukaemia Acute lymphocytic leukaemia Acute myeloid leukaemia Adult T-cell lymphoma/leukaemia Adult T-cell lymphoma/leukaemia recurrent Adverse drug reaction Agranulocytosis Allogenic stem cell transplantation Amyloidosis Anaemia Anaplastic large cell lymphoma T- and null-cell types Anaplastic large-cell lymphoma Angiocentric lymphoma Angioimmunoblastic T-cell lymphoma Angioimmunoblastic T-cell lymphoma stage III Anogenital warts Anorectal disorder Anti-myelin-associated glycoprotein associated polyneuropathy Antiviral prophylaxis Autoimmune haemolytic anaemia Autologous haematopoietic stem cell transplant B-CELL LYMPHOMA B-CELL LYMPHOMA RECURRENT B-CELL LYMPHOMA REFRACTORY B-CELL LYMPHOMA STAGE II B-CELL LYMPHOMA STAGE III B-CELL LYMPHOMA STAGE IV B-CELL PROLYMPHOCYTIC LEUKAEMIA B-CELL SMALL LYMPHOCYTIC LYMPHOMA B-CELL SMALL LYMPHOCYTIC LYMPHOMA REFRACTORY B-CELL TYPE ACUTE LEUKAEMIA B-cell aplasia B-cell lymphoma B-cell lymphoma recurrent B-cell lymphoma refractory B-cell lymphoma stage I B-cell lymphoma stage II B-cell lymphoma stage IV B-cell lymphoma unclassifiable B-cell prolymphocytic leukaemia B-cell small lymphocytic lymphoma B-cell type acute leukaemia B-cell unclassifiable lymphoma low grade BING-NEEL SYNDROME BLADDER CANCER BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASIA BLOOD COUNT ABNORMAL BLOOD DISORDER BLOOD IMMUNOGLOBULIN G BONE MARROW CONDITIONING REGIMEN BONE MARROW DISORDER BONE MARROW INFILTRATION BONE MARROW LEUKAEMIC CELL INFILTRATION BONE MARROW TRANSPLANT BREAST CANCER BREAST CANCER FEMALE BREAST CANCER METASTATIC BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA BURKITT'S LYMPHOMA BURKITT^S LYMPHOMA Bing-Neel syndrome Blood calcium Blood immunoglobulin M increased Bone marrow conditioning regimen Bone marrow infiltration Bone marrow transplant Breast cancer Breast cancer metastatic Bronchopulmonary aspergillosis Burkitt^s lymphoma Burkitt^s lymphoma recurrent Burkitt^s lymphoma stage III CANCER CD4 lymphocytes decreased CENTRAL NERVOUS SYSTEM LYMPHOMA CERVIX CARCINOMA CHEMOTHERAPY CHRONIC GRAFT VERSUS HOST DISEASE CHRONIC HEPATITIS C CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY CHRONIC LEUKAEMIA CHRONIC LYMPHOCYTIC LEUKAEMIA CHRONIC LYMPHOCYTIC LEUKAEMIA (IN REMISSION) CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT CHRONIC LYMPHOCYTIC LEUKAEMIA REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA STAGE 1 CHRONIC LYMPHOCYTIC LEUKAEMIA STAGE 2 CHRONIC LYMPHOCYTIC LEUKAEMIA STAGE 3 CHRONIC LYMPHOCYTIC LEUKAEMIA STAGE 4 CHRONIC LYMPHOCYTIC LEUKEMIA CHRONIC MYELOID LEUKAEMIA CLL COLD AGGLUTININS POSITIVE COLD TYPE HAEMOLYTIC ANAEMIA COMPOSITE LYMPHOMA CONDITION AGGRAVATED COVID-19 CRYOGLOBULINAEMIA CUTANEOUS LYMPHOMA CUTANEOUS T-CELL LYMPHOMA CYSTIC FIBROSIS CYTOMEGALOVIRUS INFECTION CYTOMEGALOVIRUS TEST POSITIVE CYTOPENIA Cardiac neoplasm malignant Central nervous system lymphoma Cervix carcinoma Chemotherapy Chronic graft versus host disease Chronic inflammatory demyelinating polyradiculoneuropathy Chronic leukaemia Chronic lymphocytic leukaemia Chronic lymphocytic leukaemia recurrent Chronic lymphocytic leukaemia refractory Chronic lymphocytic leukaemia stage 2 Chronic lymphocytic leukaemia stage 3 Chronic lymphocytic leukaemia stage 4 Chronic lymphocytic leukaemia transformation Chronic myeloid leukaemia Chronic myelomonocytic leukaemia Cold agglutinins positive Cold type haemolytic anaemia Composite lymphoma Cryoglobulinaemia Cutaneous B-cell lymphoma Cutaneous T-cell lymphoma Cutaneous T-cell lymphoma stage I Cutaneous T-cell lymphoma stage II Cystic fibrosis Cytokine release syndrome DIFFUSE LARGE B-CELL LYMPHOMA DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA STAGE II DIFFUSE LARGE B-CELL LYMPHOMA STAGE III DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV DISEASE PROGRESSION DISSEMINATED LARGE CELL LYMPHOMA DIURETIC THERAPY DOUBLE HIT LYMPHOMA DRUG THERAPY DRUG USE FOR UNKNOWN INDICATION Diffuse large B-cell lymphoma Diffuse large B-cell lymphoma recurrent Diffuse large B-cell lymphoma refractory Diffuse large B-cell lymphoma stage I Diffuse large B-cell lymphoma stage II Diffuse large B-cell lymphoma stage III Diffuse large B-cell lymphoma stage IV Disease progression Disease recurrence Diverticulitis Double hit lymphoma ENTEROPATHY-ASSOCIATED T-CELL LYMPHOMA EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA EXPOSURE TO BODY FLUID EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) RECURRENT EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) STAGE IV Enteropathy-associated T-cell lymphoma Eosinophilic cellulitis Epistaxis Epstein-Barr virus associated lymphoma Epstein-Barr virus associated lymphoproliferative disorder Epstein-Barr virus infection Epstein-Barr virus infection reactivation Epstein-Barr virus test positive Evans syndrome Evidence based treatment Extranodal marginal zone B-cell lymphoma (MALT type) Extranodal marginal zone B-cell lymphoma (MALT type) stage II Extranodal marginal zone B-cell lymphoma (MALT type) stage IV FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III REFRACTORY FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III STAGE II FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III STAGE III FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III STAGE IV FOLLICULAR B-CELL NON-HODGKIN^S LYMPHOMA FOLLICULAR DENDRITIC CELL SARCOMA FOLLICULAR LYMPHOMA FOLLICULAR LYMPHOMA STAGE III FOLLICULAR LYMPHOMA STAGE IV Fibrillary glomerulonephritis Follicle centre lymphoma, follicular grade I, II, III Follicle centre lymphoma, follicular grade I, II, III recurrent Follicle centre lymphoma, follicular grade I, II, III stage III Follicular dendritic cell sarcoma Follicular lymphoma Follicular lymphoma recurrent Follicular lymphoma refractory Follicular lymphoma stage I Follicular lymphoma stage II Follicular lymphoma stage III Follicular lymphoma stage IV GASTROINTESTINAL LYMPHOMA GLIOBLASTOMA MULTIFORME GLIOMA GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE GREY ZONE LYMPHOMA Gastrointestinal lymphoma Glomerulonephritis Glomerulonephritis proliferative Graft versus host disease Granulomatous lymphadenitis Grey zone lymphoma HAEMATOLOGICAL MALIGNANCY HAEMATOPOIETIC STEM CELL MOBILISATION HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS HAIRY CELL LEUKAEMIA HAIRY CELL LEUKAEMIA RECURRENT HEPATITIS C HEPATOSPLENIC T-CELL LYMPHOMA HERPES SIMPLEX HIGH GRADE B-CELL LYMPHOMA BURKITT-LIKE LYMPHOMA HIGH-GRADE B-CELL LYMPHOMA HISTIOCYTIC SARCOMA HISTIOCYTOSIS HIV infection HODGKIN'S DISEASE HODGKIN'S DISEASE LYMPHOCYTE PREDOMINANCE TYPE RECURRENT HODGKIN^S DISEASE HODGKIN^S DISEASE MIXED CELLULARITY STAGE IV HODGKIN^S DISEASE MIXED CELLULARITY STAGE UNSPECIFIED HODGKIN^S DISEASE NODULAR SCLEROSIS HODGKIN^S DISEASE NODULAR SCLEROSIS RECURRENT HODGKIN^S DISEASE NODULAR SCLEROSIS STAGE II HODGKIN^S DISEASE NODULAR SCLEROSIS STAGE IV HODGKIN^S DISEASE RECURRENT HODGKIN^S DISEASE REFRACTORY HODGKIN^S DISEASE STAGE II HODGKIN^S DISEASE STAGE IV HODGKIN^S LYMPHOMA HORMONE RECEPTOR POSITIVE BREAST CANCER HORMONE-REFRACTORY PROSTATE CANCER Haematological malignancy Haemolytic anaemia Haemophagocytic lymphohistiocytosis Hairy cell leukaemia Heavy chain disease Hepatic function abnormal High grade B-cell lymphoma Burkitt-like lymphoma stage IV High-grade B-cell lymphoma Hodgkin^s disease Hodgkin^s disease mixed cellularity refractory Hodgkin^s disease nodular sclerosis Hodgkin^s disease nodular sclerosis recurrent Hodgkin^s disease nodular sclerosis stage II Hodgkin^s disease nodular sclerosis stage III Hodgkin^s disease nodular sclerosis stage IV Hodgkin^s disease recurrent Hodgkin^s disease refractory Hodgkin^s disease stage IV Hypertension IDIOPATHIC INTERSTITIAL PNEUMONIA IDIOPATHIC THROMBOCYTOPENIC PURPURA ILL-DEFINED DISORDER IMMUNE THROMBOCYTOPENIA IMMUNOCHEMOTHERAPY IMMUNOGLOBULIN G4 RELATED SCLEROSING DISEASE IMMUNOSUPPRESSANT DRUG THERAPY IMMUNOSUPPRESSION INVESTIGATION IgM nephropathy Ill-defined disorder Immunochemotherapy Immunosuppressant drug therapy Immunosuppression Immunotactoid glomerulonephritis Keratopathy LARGE GRANULAR LYMPHOCYTOSIS LEUKAEMIA LEUKAEMIA RECURRENT LEUKAEMIC LYMPHOMA LEUKOCYTOSIS LEUKOPENIA LIGHT CHAIN DISEASE LUNG CANCER METASTATIC LUNG NEOPLASM MALIGNANT LYMPHADENOPATHY LYMPHATIC SYSTEM NEOPLASM LYMPHOCYTIC LEUKAEMIA LYMPHOCYTIC LYMPHOMA LYMPHOCYTOSIS LYMPHOMA LYMPHOMA TRANSFORMATION LYMPHOPLASMACYTOID LYMPHOMA/IMMUNOCYTOMA LYMPHOPLASMACYTOID LYMPHOMA/IMMUNOCYTOMA RECURRENT LYMPHOPLASMACYTOID LYMPHOMA/IMMUNOCYTOMA REFRACTORY LYMPHOPLASMACYTOID LYMPHOMA/IMMUNOCYTOMA STAGE IV LYMPHOPROLIFERATIVE DISORDER Large granular lymphocytosis Leukaemia Leukaemia recurrent Leukaemic lymphoma Light chain disease Lymphadenopathy Lymphocyte adoptive therapy Lymphocytic leukaemia Lymphocytic lymphoma Lymphocytosis Lymphodepletion Lymphoma Lymphoma transformation Lymphopenia Lymphoplasmacytoid lymphoma/immunocytoma Lymphoplasmacytoid lymphoma/immunocytoma stage IV Lymphoproliferative disorder MALIGNANT LYMPHOID NEOPLASM MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE MALIGNANT NEOPLASM PROGRESSION MALIGNANT PLEURAL EFFUSION MANTLE CELL LYMPHOMA MANTLE CELL LYMPHOMA RECURRENT MANTLE CELL LYMPHOMA REFRACTORY MANTLE CELL LYMPHOMA STAGE I MANTLE CELL LYMPHOMA STAGE II MANTLE CELL LYMPHOMA STAGE III MANTLE CELL LYMPHOMA STAGE IV MARGINAL ZONE LYMPHOMA MARGINAL ZONE LYMPHOMA RECURRENT MARGINAL ZONE LYMPHOMA STAGE IV MASS METASTASES TO BONE METASTASES TO LUNG METASTASES TO MENINGES METASTASES TO THE MEDIASTINUM METASTASIS METASTATIC BRONCHIAL CARCINOMA METASTATIC LYMPHOMA MULTIPLE MYELOMA MYASTHENIA GRAVIS MYCOSIS FUNGOIDES MYCOSIS FUNGOIDES REFRACTORY MYELODYSPLASTIC SYNDROME MYELOMA RECURRENCE Malignant histiocytosis Malignant lymphoid neoplasm Malignant neoplasm progression Malignant splenic neoplasm Mantle cell lymphoma Mantle cell lymphoma recurrent Mantle cell lymphoma refractory Mantle cell lymphoma stage II Mantle cell lymphoma stage III Mantle cell lymphoma stage IV Marginal zone lymphoma Marginal zone lymphoma recurrent Marginal zone lymphoma refractory Marginal zone lymphoma stage IV Metastases to bone Metastases to bone marrow Metastatic lymphoma Monoclonal B-cell lymphocytosis Myelodysplastic syndrome Myeloid leukaemia Myeloproliferative neoplasm NATURAL KILLER-CELL LYMPHOBLASTIC LYMPHOMA NEOPLASM NEOPLASM MALIGNANT NEURODERMATITIS NEUROENDOCRINE CARCINOMA OF THE SKIN NEUROPATHY PERIPHERAL NEUTROPENIA NODAL MARGINAL ZONE B-CELL LYMPHOMA NODAL MARGINAL ZONE B-CELL LYMPHOMA STAGE IV NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA NON-HODGKIN'S LYMPHOMA NON-HODGKIN'S LYMPHOMA RECURRENT NON-HODGKIN'S LYMPHOMA STAGE IV NON-HODGKIN'S LYMPHOMA UNSPECIFIED HISTOLOGY INDOLENT NON-HODGKIN^S LYMPHOMA NON-HODGKIN^S LYMPHOMA RECURRENT NON-HODGKIN^S LYMPHOMA REFRACTORY NON-HODGKIN^S LYMPHOMA STAGE II NON-HODGKIN^S LYMPHOMA STAGE III NON-HODGKIN^S LYMPHOMA STAGE IV NON-HODGKIN^S LYMPHOMA UNSPECIFIED HISTOLOGY AGGRESSIVE STAGE I NON-HODGKIN^S LYMPHOMA UNSPECIFIED HISTOLOGY INDOLENT NON-SMALL CELL LUNG CANCER NUTRITIONAL SUPPLEMENTATION Neoplasm Neoplasm malignant Neoplasm prophylaxis Neoplasm recurrence Neutropenia Night sweats Nijmegen breakage syndrome Nodal marginal zone B-cell lymphoma Nodal marginal zone B-cell lymphoma stage III Nodal marginal zone B-cell lymphoma stage IV Nodular lymphocyte predominant Hodgkin lymphoma Non-Hodgkin^s lymphoma Non-Hodgkin^s lymphoma recurrent Non-Hodgkin^s lymphoma refractory Non-Hodgkin^s lymphoma stage II Non-Hodgkin^s lymphoma stage III Non-Hodgkin^s lymphoma stage IV Non-Hodgkin^s lymphoma unspecified histology aggressive stage III Non-Hodgkin^s lymphoma unspecified histology indolent OCCUPATIONAL EXPOSURE TO PRODUCT OCULAR LYMPHOMA OESOPHAGEAL CARCINOMA OFF LABEL USE ONCOLOGIC COMPLICATION OVARIAN CANCER Ocular lymphoma Oedema Off label use PAIN PANCREATIC FAILURE PAPILLARY THYROID CANCER PARANEOPLASTIC PEMPHIGUS PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED RECURRENT PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED REFRACTORY PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE III PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE IV PLASMA CELL LEUKAEMIA PLASMA CELL MYELOMA PLASMA CELL MYELOMA IN REMISSION PLASMA CELL MYELOMA RECURRENT PLASMABLASTIC LYMPHOMA PLASMACYTOMA PLEURAL EFFUSION PLEURAL MESOTHELIOMA MALIGNANT POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER PRECURSOR B-LYMPHOBLASTIC LYMPHOMA PREMEDICATION PRIMARY AMYLOIDOSIS PRIMARY GASTROINTESTINAL FOLLICULAR LYMPHOMA PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA STAGE II PRODUCT USE IN UNAPPROVED INDICATION PRODUCT USED FOR UNKNOWN INDICATION PROLYMPHOCYTIC LEUKAEMIA PROPHYLAXIS PROPHYLAXIS AGAINST GRAFT VERSUS HOST DISEASE Pain Palliative care Pancytopenia Paraneoplastic glomerulonephritis Paraneoplastic syndrome Parkinson^s disease Peripheral T-cell lymphoma unspecified Peripheral T-cell lymphoma unspecified refractory Peripheral T-cell lymphoma unspecified stage IV Plasma cell leukaemia Plasma cell myeloma Plasma cell myeloma recurrent Plasma cell myeloma refractory Plasmablastic lymphoma Plasmacytoma Pleural effusion Post transplant lymphoproliferative disorder Precursor T-lymphoblastic lymphoma/leukaemia Premedication Primary amyloidosis Primary cardiac lymphoma Primary effusion lymphoma Primary gastrointestinal follicular lymphoma Primary mediastinal large B-cell lymphoma Primary mediastinal large B-cell lymphoma refractory Primary mediastinal large B-cell lymphoma stage II Product use in unapproved indication Product used for unknown indication Prophylaxis Prophylaxis against graft versus host disease Prophylaxis against transplant rejection Prophylaxis of nausea and vomiting Pruritus RASH RECURRENT CANCER RENAL CELL CARCINOMA RICHTER^S SYNDROME Rash Rectal cancer Refractory cancer Renal amyloidosis Renal impairment Rheumatoid arthritis Richter^s syndrome SALVAGE THERAPY SJOGREN^S SYNDROME SMALL CELL LUNG CANCER EXTENSIVE STAGE SMALL CELL LUNG CANCER METASTATIC SMALL CELL LUNG CANCER RECURRENT SMALL CELL LUNG CANCER STAGE UNSPECIFIED SMALL LYMPHOCYTIC LYMPHOMA, CONSISTENT WITH CLL (WORKING FORMULATION) REFRACTORY SPLENIC MARGINAL ZONE LYMPHOMA SPLENIC MARGINAL ZONE LYMPHOMA RECURRENT SPLENIC MARGINAL ZONE LYMPHOMA STAGE III SPLENIC MARGINAL ZONE LYMPHOMA STAGE IV SPLENOMEGALY STEM CELL TRANSPLANT SYSTEMIC INFECTION SYSTEMIC LUPUS ERYTHEMATOSUS Salvage therapy Secondary amyloidosis Skin disorder Splenic marginal zone lymphoma Splenic marginal zone lymphoma stage III Splenic marginal zone lymphoma stage IV Splenomegaly Stem cell transplant Subdural haematoma Surgical preconditioning T-CELL LYMPHOMA T-CELL LYMPHOMA STAGE IV T-CELL PROLYMPHOCYTIC LEUKAEMIA T-CELL TYPE ACUTE LEUKAEMIA T-cell lymphoma T-cell lymphoma stage IV T-cell prolymphocytic leukaemia THERAPY NAIVE THROMBOCYTOPENIA THYROID MASS TONSIL CANCER TRANSPLANT TRIPLE HIT LYMPHOMA TUMOUR LYSIS SYNDROME Triple hit lymphoma WALDENSTROM'S MACROGLOBULINAEMIA WALDENSTROM^S MACROGLOBULINAEMIA WALDENSTROM^S MACROGLOBULINAEMIA RECURRENT WALDENSTROM^S MACROGLOBULINAEMIA REFRACTORY WALDENSTROM^S MACROGLOBULINAEMIA STAGE IV WALDENSTROM^S MACROGLOBULINEMIA WHITE BLOOD CELL COUNT INCREASED Waldenstrom^s macroglobulinaemia Waldenstrom^s macroglobulinaemia recurrent Waldenstrom^s macroglobulinaemia refractory Waldenstrom^s macroglobulinaemia stage IV XANTHOGRANULOMA Xanthogranuloma Bendamustine brand names and reporting trend
Bendamustine is sold under the brand name Bendeka.
Quarterly reports (2004–2025) An upward trend reflects increased FAERS reporting overall, not necessarily increased risk.
Taking bendamustine with another medication? Ask OpenClaim about your specific drug combination. Get a sourced report using FDA data, drug labels, and medical literature.